Hotline for Health Services for Displaced Lebanese 1787
Hotline for the Patient Admission to Hospitals 01/832700
COVID-19 Vaccine Registration Form covax.moph.gov.lb
MoPH Hotline 1214
Are you a new member? Sign up now
 
Let us help you
Read about the latest topics.

New Procedures for Incoming Passengers starting 27/9/2022

 


Procedures for All Incoming Passengers to Lebanon
 
Privacy Policy
The data on this platform is processed in line with the laws in force in the Lebanese Republic, especially the Law of Electronic Transactions and Personal Data No. 81 of 10/10/2018.

The data is currently hosted on a secure cloud that is ISO27001, NIST 800-53 and GDPR compliant and all security requirements are in place to secure the infrastructure. The data and application hosting will be migrated to a secure national datacenter at a later stage.

Work is done with a company specialized in information protection and security and all security requirements on this platform and all security requirements are based on: OWASP Top 10 web applications security risks, OWASP Top 10 API security and OWASP ASVS best practices were taken into consideration during the development phase. Penetration tests are being conducted on the test environment in order to ensure that no vulnerabilities exist before the live implementation. Ongoing penetration tests and checks are being conducted on the live environment in order to ensure that both environments are secured.

We ensure to maintain the confidentiality of your information and provide physical, electronic and procedural safeguards to ensure the protection of the information we process and keep on a secure server. Your data is shared with the laboratory to input the result of the PCR test result done at the airport and the result is sent to your phone via an SMS.

The information you disclosed, such as your name, your father's name, first name, date of birth and place of residence, is encrypted and stored in a secure manner and cannot be accessed by the public, and you have the right to view, correct, modify or delete your data from the database.

We will use your personal information if you are infected with the Coronavirus and you were tested positive for COVID-19 or have been in contact with a positive case, to contact you and give you the necessary directions. Your data will be shared with the Ministry of Interior and Municipalities in order to take preventive measures such as isolation or to do a PCR test to limit the spread of the virus.

Storing this data aims to confront a global epidemic, to contribute to limiting the spread of the Covid-19 epidemic, and to preserve the public health in the Lebanese Republic.


The Privacy Policy
 
MOPH PASS Refund 
Refund Policy:
If you registered on the
https://pass.moph.gov.lb  platform and paid the cost of the PCR test via credit card or via the electronic document EMD and decided not to travel to Lebanon or postpone the travel, you can submit a request for a refund in writing to PASS@MOPH.GOV.LB  within a month of registering on the platform.
All refund requests will be reviewed and evaluated based on the payment status and arrival in Lebanon before a decision is made.
The Ministry reserves the right to refuse a refund based on the data registered in the platform.

MOPH PASS Refund Request
 
Memos and Decisions
 
 




    ...
    117
    ...
ATC Name B/G Ingredients Dosage Form Price
L01EG02 EVEROLIMUS BIOGARAN G Everolimus - 2.5mg 2.5mg Tablet 52,290,378 L.L
L01EG02 EVEROLIMUS BIOGARAN G Everolimus - 5mg 5mg Tablet L.L
L01EG02 EVEROLIMUS BIOGARAN G Everolimus - 10mg 10mg Tablet L.L
L01EH01 TYKERB B Lapatinib ditosylate - 250mg 250mg Tablet, film coated 101,971,611 L.L
L01EJ01 JAKAVI B Ruxolitinib - 5mg 5mg Tablet 172,845,338 L.L
L01EJ01 CELEZON G Ruxolitinib - 5mg 5mg Tablet 95,532,998 L.L
L01EJ01 JAKAVI B Ruxolitinib - 15mg 15mg Tablet 341,075,567 L.L
L01EJ01 CELEZON G Ruxolitinib - 15mg 15mg Tablet 188,515,591 L.L
L01EJ01 JAKAVI B Ruxolitinib - 20mg 20mg Tablet 341,075,567 L.L
L01EJ01 CELEZON G Ruxolitinib - 20mg 20mg Tablet 188,515,591 L.L
L01EJ01 CELEZON G Ruxolitinib - 5mg 5mg Tablet L.L
L01EJ01 CELEZON G Ruxolitinib - 15mg 15mg Tablet L.L
L01EJ01 CELEZON G Ruxolitinib - 20mg 20mg Tablet L.L
L01EK01 INLYTA B Axitinib - 5mg 5mg Tablet, film coated 184,486,511 L.L
L01EK01 INLYTA B Axitinib - 1mg 1mg Tablet, film coated 57,595,789 L.L
L01EL01 IMBRUVICA B Ibrutinib - 420mg 420mg Tablet, film coated L.L
L01EL01 IMBRUVICA B Ibrutinib - 140mg 140mg Tablet, film coated 194,761,420 L.L
L01EL01 DULLARMA G Ibrutinib - 140mg 140mg Capsule, hard 422,860,803 L.L
L01EL01 IMBRUVICA B Ibrutinib - 420mg 420mg Tablet, film coated 584,283,050 L.L
L01EL01 DULLARMA G Ibrutinib - 140mg 140mg Capsule, hard L.L
L01EL02 CALQUENCE B Acalabrutinib - 100mg 100mg Tablet, film coated 650,653,454 L.L
L01EM03 PIQRAY B Alpelisib - 150mg 150mg Tablet, film coated 359,195,954 L.L
L01EM03 PIQRAY B Alpelisib - 200mg, Alpelisib - 50mg 150mg Tablet, film coated 359,195,954 L.L
L01EX01 SUTENT B Sunitinib maleate - 12.5mg 12.5mg Capsule L.L
L01EX01 SUTENT B Sunitinib maleate - 50mg 50mg Capsule L.L
L01EX01 SUTENT B Sunitinib maleate - 12.5mg 12.5mg Capsule 54,006,801 L.L
L01EX01 SOVIDEX G Sunitinib maleate - 12.5mg 12.5mg Capsule 36,042,560 L.L
L01EX01 SUNITINIB AQVIDA G Sunitinib maleate - 12.5mg 12.5mg Capsule, hard 35,585,027 L.L
L01EX01 SUTENT B Sunitinib maleate - 25mg 25mg Capsule 98,852,769 L.L
L01EX01 SOVIDEX G Sunitinib maleate - 25mg 25mg Capsule 64,804,314 L.L
    ...
    117
    ...
Sitemap
© Copyrights reserved to Ministry of Public Health 2025